07 Nov 2022
// ACCESSWIRE
https://www.accesswire.com/724162/Relief-Therapeutics-Announces-Six-Month-Stability-Data-on-a-New-Formulation-of-RLF-100-Aviptadil
03 Aug 2022
// ACCESSWIRE
https://www.accesswire.com/710682/Relief-Therapeutics-Announces-Promising-Initial-Stability-Data-on-a-New-Formulation-of-RLF-100R-Aviptadil
02 Jul 2022
// Nick Paul Taylor FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/deja-vu-fda-rejects-nrx-filing-emergency-use-covid-19
10 Jun 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-provides-update-on-breakthrough-therapy-designation-btd-request-for-zyesami-aviptadil-301566128.html
27 May 2022
// N.P. Taylor FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/activ-nrx-tanks-peptide-fails-nih-trial-severe-covid-19-patients
27 May 2022
// CLINICALTRIALSARENA
https://www.clinicaltrialsarena.com/news/nrx-zyesami-covid-futility/
LOOKING FOR A SUPPLIER?